-0.02 | -2.70%
| Price and Volume | |
|---|---|
| Recent Price | 0.74 |
| 52 Week High | 0.94 |
| 52 Week Low | 0.55 |
| Avg. Daily Vol. (Mil) | 0.01 |
| Beta (3 year) | 1.17 |
| Share Related Items | |
| Mkt Cap (Mil) | 23.00 |
| Shares Out (Mil) | 31.08 |
| Float (Mil) | 11.89 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.10 |
| Current Ratio | 1.70 |
| LT Debt/ Equity | 0.02 |
| Total Debt / Equity | 0.44 |
| Valuation Ratios | |
| Price Earnings | 10.60 |
| Price/Sales | 0.63 |
| Price/Book | 2.16 |
| Price/Cash Flow | 7.90 |
| Per Share Data | |
| Earnings | 0.07 |
| Sales | 1.17 |
| Book Value | 0.34 |
| Cash Flow | 0.09 |
| Business Summary | |
|---|---|
| Zynex, Incorporated designs, assembles and commercializes a line of FDA cleared medical devices for the electrotherapy and stroke rehabilitation markets. | |
| General Information | |
| 9990 Park Meadows Dr
Lone Tree, CO 80126 |
|
| www.zynexmed.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 233 | |
| CEO: Thomas Sandgaard | |
| Short Interest | |
| Current Month (Mil) | 0.00 |
| Previous Month (Mil) | 0.00 |
| Short Interest Ratio (Days) | 0.00 |
| Management Effectiveness | |
| Return on Equity | 18.70 |
| Return on Assets | 8.30 |
| Return on Investments | 18.30 |
| Profitability | |
| Gross Margin | 81.30 |
| EBIT Margin | 10.20 |
| Profit Margin | 5.50 |
|
Latest ZYXI Headlines
Press Releases for ZYXI
|
Partner Headlines
|
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,372.71 | 1,313.41 | 2,815.75 | 16.02 |
Oil *
103.24
|
|
DOWN
47.15 |
UP
0.09 |
DOWN
21.61 |
DOWN
0.23 |
10 Yr
1.60%
SPDR Gold
152.19
|
|
-0.38%
|
+0.01%
|
-0.76%
|
-1.42%
|
Data delayed 20 minutes |
Connect with TheStreet